SCHEMBL9889117

SCHEMBL9889117

CSCC(C(=O)O)N(CC(=O)O)CC(=O)O

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RNPEP Q9H4A4 1/20 0.33
FOLH1 Q04609 1/20 0.32
TDP1 Q9NUW8 2/20 0.32
EYA2 O00167 1/20 0.32
APP P05067 1/20 0.32
ACE P12821 1/20 0.32
BHMT Q93088 1/20 0.32
KDM4E B2RXH2 1/20 0.31
LMNA P02545 1/20 0.31
CHRM2 P08172 1/20 0.31
ADRA2A P08913 1/20 0.31
ALOX15 P16050 1/20 0.31
TSHR P16473 1/20 0.31
DRD1 P21728 1/20 0.31
SLC6A2 P23975 1/20 0.31
SLC6A4 P31645 1/20 0.31
CYP2C19 P33261 1/20 0.31
ADRA1A P35348 1/20 0.31
DRD3 P35462 1/20 0.31
BLM P54132 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2250788 0.84 TDP1 (0.33) TDP1EYA2APPACEKDM4E
SCHEMBL2250779 0.84 TDP1 (0.33) TDP1EYA2APPACEKDM4E
SCHEMBL5590884 0.79 CYP2D6 (0.42) TDP1EYA2APPACEBHMT
SCHEMBL957226 0.77 FFAR3 (0.35) TDP1EYA2APPACEBHMT
SCHEMBL215964 0.77 FFAR3 (0.35) TDP1EYA2APPACEBHMT
SCHEMBL9972817 0.76
SCHEMBL3290225 0.75 BHMT (0.37) TDP1EYA2APPACEBHMT
SCHEMBL13090504 0.75
SCHEMBL3290209 0.75 BHMT (0.37) TDP1EYA2APPACEBHMT
SCHEMBL22313 0.75 TDP1 (0.42) FOLH1TDP1EYA2APPACE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150369816-A1 Polypeptide Immobilization UNIV CHICAGO (US) 2015-12-24 US disclosed
US-20150369816-A1 Polypeptide Immobilization UNIV CHICAGO (US) 2015-12-24 US disclosed
US-9074300-B2 Polypeptide immobilization THE UNIVERSITY OF CHICAGO (US) 2015-07-07 US disclosed
US-9074300-B2 Polypeptide immobilization THE UNIVERSITY OF CHICAGO (US) 2015-07-07 US disclosed
EP-1552305-B1 POLYPEPTIDE IMMOBILIZATION UNIV CHICAGO (US) 2013-07-31 EP disclosed
US-20120142547-A1 POLYPEPTIDE IMMOBILIZATION THE UNIVERSITY OF CHICAGO 2012-06-07 US disclosed
US-20120142547-A1 POLYPEPTIDE IMMOBILIZATION THE UNIVERSITY OF CHICAGO 2012-06-07 US disclosed
EP-2311939-A1 Polypeptide immobilization The University of Chicago (US) 2011-04-20 EP disclosed
US-7888055-B2 Selectively binds with absolute control over orientation and density without requiring prior synthetic modification or purification to make a stable protein chip; rapid and irreversible; assaying kinase or protease activity THE UNIVERSITY OF CHICAGO (US) 2011-02-15 US disclosed
US-7888055-B2 Selectively binds with absolute control over orientation and density without requiring prior synthetic modification or purification to make a stable protein chip; rapid and irreversible; assaying kinase or protease activity THE UNIVERSITY OF CHICAGO (US) 2011-02-15 US disclosed
US-20080064606-A1 Polypeptide immobilization THE UNIVERSITY OF CHICAGO 2008-03-13 US disclosed
US-20080064606-A1 Polypeptide immobilization THE UNIVERSITY OF CHICAGO 2008-03-13 US disclosed
US-7172905-B2 Polypeptide immobilization THE UNIVERSITY OF CHICAGO (US) 2007-02-06 US disclosed
US-7172905-B2 Polypeptide immobilization THE UNIVERSITY OF CHICAGO (US) 2007-02-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080064606-A1 Polypeptide immobilization QPCTL, SURF4, QPCT RNPEP 387/4885FOLH1 1496/4885TDP1 1808/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.